Another peptide that was nominated as a way to treat obesity and osteoporosis, MOTS-c, had not been evaluated in any published human studies either, the scientists found
Its ability to promote elastin and collagen production makes it a highly sought-after ingredient in anti-aging skincare, where the effects of GHK-CU can help reduce the appearance of fine lines, improve skin firmness, reduce visible signs of aging and enhance overall skin appearance
(Neither the FDA nor HHS responded to ProPublicas requests for more information.) But several regulatory shortcuts exist and, ultimately, Kennedy could simply declare the ingredients are legal
The FDA also notes that no safety-related information regarding DSIP has been identified, so its unknown whether it could be harmful to humans.26 Given these conclusions, we shouldnt be surprised that DSIP is not an FDA-approved peptide therapy
Cycle length and time off Using IGF-1 LR3 for too long can lead to reduced effectiveness over time